More articles from MTA I: Prostate/GU Posters

You have access
Whole-Body Scintigraphy and Quantitative SPECT/CT Using the PSMA-Agent Tc-99m-MIP-1404 in the Preoperative Staging of Prostate Cancer - Preliminary Results
Michael Beck, Julia Reinfelder, Philipp Ritt, James Sanders and Kuwert Torsten

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1545;
You have access
Clinical study of 68Ga labeled homologue of gastrin-releasing peptide for PET/CT imaging of patient with prostate cancer
Xiaowei Ma, Shengjun Wang, Yao Sun, Yongheng Gao, Daliang Liu, Fei Kang, Weidong Yang, Zhen Cheng and Jing Wang

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1557;
You have access
Evaluation of the prognostic impact of 18F-Choline PET/CT in patients with skeletal recurrence prostate cancer
Laura Evangelista, Fabio Zattoni, Emanuela Agostini, Andrea Guttilla, Giorgio Saladini and Zattoni Filiberto

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1552;
You have access
SPECT/CT Imaging of Prostatic PSMA Expression with Tc99m trofolastat chloride in Healthy Volunteers
Mustafa Bashir, Thomas Armor, Brandon Howard, Kimberly Lynch, Neil Petry, Lucian Cappoli, Salvador Borges-Neto, Pete Manspeaker, Nancy Stambler and Vivien Wong

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1546;
You have access
Comparative assessment of skeletal uptake on Ga-68 PSMA PET/CT versus F-18 Fluoride PET/CT in metastatic prostate cancer
AVIRAL SINGH, Harshad Kulkarni, Karin Niepsch and Richard Baum

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1543;
You have access
18F-FDG PET/CT in the follow-up of asymptomatic RCC patients after surgery : Can substitute conventional imaging?
Sohyun Park, Ho-Young Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1564;
You have access
Role of F-18 FDG PET/CT in restaging of patients with renal cell carcinoma: experience at a single tertiary care centre
ABHIRAM JOIS, Rajender Kumar, Apurva Sood, Anish Bhattacharya, Shrawan Singh and Bhagwant Mittal

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1566;
You have access
Evidence of the effectiveness of reader training for the staging of biochemically recurrent prostate cancer using fluciclovine F18 PET-CT.
Matthew Miller, Lale Kostakoglu, Daniel Pryma, Jian Qin Yu, Albert Chau, Eric Perlman, Bonnie Clarke, Donald Rosen, David Gauden and Penny Ward

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1556;
You have access
PATHOLOGICAL SENTINEL LYMPH NODE STATUS IN MORE 200 PROSTATE CANCER PATIENTS: WHAT IMPACT ON SURVIVAL WITHOUT RECURRENCE?
Caroline ROUSSEAU, Jacques Lacoste, Marie Lacombe, Eric Potiron, DaniÃ©la Rusu, Pierre Nevoux, Mathilde Colombie, Vincent Fleury, Francoise Bodere, LoÃ¯c Campion and Thierry Rousseau

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1561;
You have access
Rising PSA after curative I125 brachytherapy in prostate cancer: patterns of 18F-Choline prostatic uptake on PET/CT.
Anne Laure Cazeau, Eivind Blais, Jean Luc Hoepffner, Thierry Piechaud, Celine Merino, Philippe Stein, AXELLE DUTERTRE and Laurence Thomas

Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 1549;

Main menu

User menu

Search

More articles from MTA I: Prostate/GU Posters

Pages